Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BT-114143 vs tranexamic acid in unilateral total knee arthroplasty
ChiCTR2500106191Phase 2Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of BT-114143 in osteoarthritis (OA) (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Total Blood Loss. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
BT-114143
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2500106191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106191.